The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...

Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in. On December 4, Jefferies reiterated a ...

Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

NEW YORK – A gene therapy using lentiviral particles to generate CAR T cells inside multiple myeloma patients has shown the ability to eliminate the small number of cancer cells in the bone marrow ...

“In our real-world experience, [Yescarta] in relapsed or refractory follicular lymphoma showed durable responses and a ...

Researchers also discussed access barriers at the meeting, and a survey found distance was a major hindrance to CAR-T ...

The CAR T Vision Steering Committee members wish to double the number of eligible patients receiving chimeric antigen ...

Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...

Patients with previously incurable cancer are seeing incredible results thanks to a pioneering new treatment that has just ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...